Artículos por temáticas

Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease

Solla P, Masala C, Liscia A, Piras R, Ercoli T, Fadda L, Hummel T, Haenher A, Defazio G.

J Neurol. 2020 Jan;267(1):57-63. doi: 10.1007/s00415-019-09551-2. Epub 2019 Sep 25.

Quantitative associations between objective sleep measures and early-morning mobility in Parkinson's disease: cross-sectional analysis of the PHASE study.

Kataoka H, Saeki K, Yamagami Y, Sugie K, Obayashi K.

Sleep. 2020 Jan 13;43(1). pii: zsz203. doi: 10.1093/sleep/zsz203.

A new semi-supervised approach for characterizing the Arabic on-line handwriting of Parkinson's disease patients

Ammour A, Aouraghe I, Khaissidi G, Mrabti M, Aboulem G, Belahsen F.

Comput Methods Programs Biomed. 2020 Jan;183:104979. doi: 10.1016/j.cmpb.2019.07.007. Epub 2019 Jul 8.

Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease

Xu JT, Qian Y, Wang W, Chen XX, Li Y, Li Y, Yang ZY, Song XB, Lu D, Deng XL.

Neural Regen Res. 2020 Jan;15(1):112-119. doi: 10.4103/1673-5374.264470.

Stem cell therapy for Parkinson's disease: safety and modeling

Stoddard-Bennett T, Pera RR.

Neural Regen Res. 2020 Jan;15(1):36-40. doi: 10.4103/1673-5374.264446.

Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis?

Quattrone D, Richards A, Reininghaus U, Vassos E, O'Donovan M, Lewis C, Di Forti M.

Psychol Med. 2020 Jan;50(1):173-176. doi: 10.1017/S0033291719002435. Epub 2019 Sep 19.

Pharmacological targeting of β(2) -adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease

O'Neill E, Yssel JD, McNamara C, Harkin A.

Br J Pharmacol. 2020 Jan;177(2):282-297. doi: 10.1111/bph.14862. Epub 2019 Dec 12.

Association between fatigue and motor progression in Parkinson's disease in southern Chinese

Yu HX, Guo MR, Li G, Zhang B.

Neurol Sci. 2020 Jan;41(1):161-164. doi: 10.1007/s10072-019-04059-z. Epub 2019 Sep 4.

Understanding the links between cardiovascular disease and Parkinson's disease

Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C.

Mov Disord. 2020 Jan;35(1):55-74. doi: 10.1002/mds.27836. Epub 2019 Sep 4.

Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease

Parra I, Martínez I, Ramírez-García G, Tizabi Y, Mendieta L.

Neurotox Res. 2020 Jan;37(1):1-11. doi: 10.1007/s12640-019-00104-z. Epub 2019 Sep 2.

Functional Motor Symptoms in Parkinson's Disease and Functional Parkinsonism: A Systematic Review.

Ambar Akkaoui M, Geoffroy PA, Roze E, Degos B, Garcin B.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):4-13. doi: 10.1176/appi.neuropsych.19030058. Epub 2019 Aug 30.

Home-based monitoring of falls using wearable sensors in Parkinson's disease

Silva de Lima AL, Smits T, Darweesh SKL, Valenti G, Milosevic M, Pijl M, Baldus H, de Vries NM, Meinders MJ, Bloem BR.

Mov Disord. 2020 Jan;35(1):109-115. doi: 10.1002/mds.27830. Epub 2019 Aug 26.

A neurophysiological investigation of anticipation to pain in Parkinson's disease

Martin SL, Jones AKP, Brown CA, Kobylecki C, Silverdale MA.

Eur J Neurosci. 2020 Jan;51(2):611-627. doi: 10.1111/ejn.14559. Epub 2019 Sep 13.

Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson's disease: a systematic review

Jiang DQ, Wang HK, Wang Y, Li MX, Jiang LL, Wang Y.

Neurol Sci. 2020 Jan;41(1):101-109. doi: 10.1007/s10072-019-04050-8. Epub 2019 Aug 24.

Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson's disease: a pilot study

Liu G, Chen H, Su D, Wang D, Zhang M, Wang X, Wang Z, Yang Y, Jiang Y, Ma H, Feng T.

Neurol Sci. 2020 Jan;41(1):111-118. doi: 10.1007/s10072-019-04043-7. Epub 2019 Aug 24.